The results suggest that expression of ALKBH5, IGF2BP2, METTL16, AL513165.1, and AP005233.2 is significantly associated with tumor stage and that expression of UCA1, IGF2BP2, METTL16, AL513165.1, AP005233.2, and AC099850.3 is significantly associated with tumor grade. The gene discussed is METTL16; the disease is neoplasm.